Racial differences in the prevalence of Factor V Leiden mutation among patients on chronic warfarin therapy

Blood Cells, Molecules, and Diseases

Volumn 37, Issue 2, 2006, Pages 100-106

  Limdi, N A ^a   Beasley, T M ^b   Allison, D B ^b   Rivers, C A ^c   Acton, R T ^b,c  

^a The University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

African American; Arterial and venous thrombosis; European American; Factor V Leiden; Prevalence

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; WARFARIN;

ADULT; AFRICAN AMERICAN; AGED; ARTERY EMBOLISM; ARTICLE; CHI SQUARE TEST; COHORT ANALYSIS; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; STATISTICAL ANALYSIS; VENOUS THROMBOEMBOLISM;

AFRICAN AMERICANS; ALABAMA; ANTICOAGULANTS; CHRONIC DISEASE; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACTOR V; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; WARFARIN;

EID: 33748860865     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2006.06.003     Document Type: Article

References (50)

1. Adcock D.M., Fink L., and Marlar R.A. A laboratory approach to the evaluation of hereditary hypercoagulability. Am. J. Clin. Pathol. 108 (1997) 434-449
2. Rosendaal F.R. Venous thrombosis: prevalence and interaction of risk factors. Haemostasis 29 Suppl. S1 (1999) 1-9
3. Rosendaal F.R. Venous thrombosis: a multicausal disease. Lancet 353 (1999) 1167-1173
4. Lane D.A., Mannucci P.M., Bauer K.A., Bertina R.M., Bochkov N.P., Boulyjenkov V., Chandy M., Dahlback B., Ginter E.K., Miletich J.P., Rosendaal F.R., and Seligsohn U. Inherited thrombophilia: Part 2. Thromb. Haemostasis 76 (1996) 824-834
5. Lane D.A., Mannucci P.M., Bauer K.A., Bertina R.M., Bochkov N.P., Boulyjenkov V., Chandy M., Dahlback B., Ginter E.K., Miletich J.P., Rosendaal F.R., and Seligsohn U. Inherited thrombophilia: Part 1. Thromb. Haemostasis 76 (1996) 651-662
6. Bertina R.M., Koeleman B.P., Koster T., Rosendaal F.R., Dirven R.J., de Ronde H., van der Velden P.A., and Reitsma P.H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 (1994) 64-67
7. Bauer K.A. Laboratory markers of coagulation activation. Arch. Pathol. Lab. Med. 117 (1993) 71-77
8. Seligsohn U., and Lubetsky A. Genetic susceptibility to venous thrombosis. N. Engl. J. Med. 344 (2001) 1222-1231
9. Austin H., Hooper W.C., Dilley A., Drews C., Renshaw M., Ellingsen D., and Evatt B. The prevalence of two genetic traits related to venous thrombosis in whites and African-Americans. Thrombosis Res. 86 (1997) 409-415
10. De Stefano V., Chiusolo P., Paciaroni K., and Leone G. Epidemiology of factor V Leiden: clinical implications. Semin. Thromb. Hemostasis 24 (1998) 367-379
11. Manten B., Westendorp R.G., Koster T., Reitsma P.H., and Rosendaal F.R. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation. (see comment). Thromb. Haemostasis 76 (1996) 510-513
12. Price D.T., and Ridker P.M. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann. Int. Med. 127 (1997) 895-903
13. Ridker P.M., Miletich J.P., Stampfer M.J., Goldhaber S.Z., Lindpaintner K., and Hennekens C.H. Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation 92 (1995) 2800-2802
14. Rosendaal F.R., Koster T., Vandenbroucke J.P., and Reitsma P.H. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85 (1995) 1504-1508
15. Simioni P., Prandoni P., Lensing A.W., Scudeller A., Sardella C., Prins M.H., Villalta S., Dazzi F., and Girolami A. The risk of recurrent venous thromboembolism in patients with an Arg506 → Gln mutation in the gene for factor V (factor V Leiden). N. Engl. J. Med. 336 (1997) 399-403
16. van der Meer F.J., Koster T., Vandenbroucke J.P., Briet E., and Rosendaal F.R. The Leiden Thrombophilia Study (LETS). Thromb. Haemostasis 78 (1997) 631-635
17. Vandenbroucke J.P., and Rosendaal F.R. Factor V Leiden and venous thromboembolism. Ann. Int. Med. 141 (2004) 484
18. Nabavi D.G., Junker R., Wolff E., Ludemann P., Doherty C., Evers S., Droste D.W., Kessler C., Assmann G., and Ringelstein E.B. Prevalence of factor V Leiden mutation in young adults with cerebral ischaemia: a case-control study on 225 patients. J. Neurol. 245 (1998) 653-658
19. Kontula K., Ylikorkala A., Miettinen H., Vuorio A., Kauppinen-Makelin R., Hamalainen L., Palomaki H., and Kaste M. Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb. Haemostasis 73 (1995) 558-560
20. Kim R.J., and Becker R.C. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am. Heart J. 146 (2003) 948-957
21. Juul K., Tybjaerg-Hansen A., Steffensen R., Kofoed S., Jensen G., and Nordestgaard B.G. Factor V Leiden: the Copenhagen City Heart Study and 2 meta-analyses. Blood 100 (2002) 3-10
22. Doggen C.J., Cats V.M., Bertina R.M., and Rosendaal F.R. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. (see comment). Circulation 97 (1998) 1037-1041
23. Ridker P.M., Hennekens C.H., Lindpaintner K., Stampfer M.J., Eisenberg P.R., and Miletich J.P. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. (see comment). N. Engl. J. Med. 332 (1995) 912-917
24. N. Limdi, Pharmacogenetic optimization of anticoagulation therapy.
25. Hezard N., Cornillet P., Droulle C., Gillot L., Potron G., and Nguyen P. Factor V Leiden: detection in whole blood by ASA PCR using an additional mismatch in antepenultimate position. Thrombosis Res. 88 (1997) 59-66
26. Hezard N., Cornillet-Lefebvre P., Gillot L., Potron G., and Nguyen P. Multiplex ASA PCR for a simultaneous determination of factor V Leiden gene, G → A 20210 prothrombin gene and C → T 677 MTHFR gene mutations. Thromb. Haemostasis 79 (1998) 1054-1055
27. Lynch M W.B. Genetics and Analysis of Quantitative Traits (1998), Sinauer Associates, Inc., Sunderland, MA
28. Maldonado G., and Greenland S. Simulation study of confounder-selection strategies. Am. J. Epidemiol. 138 (1993) 923-936
29. Rees D.C., Cox M., and Clegg J.B. World distribution of factor V Leiden. Lancet 346 (1995) 1133-1134
30. Svensson P.J., Zoller B., Mattiasson I., and Dahlback B. The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis. J. Int. Med. 241 (1997) 379-385
31. Tosetto A., Missiaglia E., Gatto E., and Rodeghiero F. The VITA project: phenotypic resistance to activated protein C and FV Leiden mutation in the general population. Vicenza Thrombophilia and Atherosclerosis. Thromb. Haemostasis 78 (1997) 859-863
32. Rees D.C. The population genetics of factor V Leiden (Arg506Gln). Br. J. Haematol. 95 (1996) 579-586
33. Bauduer F., and Lacombe D. Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677T, and population genetics. Mol. Genet. Metab. 86 (2005) 91-99
34. Al-Aama J.Y. Prevalence of factor V Leiden and prothrombin G20210A gene mutation. Saudi Med. J. 26 (2005) 1844
35. Ridker P.M., Miletich J.P., Hennekens C.H., and Buring J.E. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 277 (1997) 1305-1307
36. Dowling N.F., Austin H., Dilley A., Whitsett C., Evatt B.L., and Hooper W.C. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study. J. Thromb. Haemostasis 1 (2003) 80-87
37. Dilley A., Austin H., Hooper W.C., Lally C., Ribeiro M.J., Wenger N.K., Silva V., Rawlins P., and Evatt B. Relation of three genetic traits to venous thrombosis in an African-American population. Am. J. Epidemiol. 147 (1998) 30-35
38. Hooper W.C., Dilley A., Ribeiro M.J., Benson J., Austin H., Silva V., Rawlins P., Wenger N.K., and Evatt B.L. A racial difference in the prevalence of the Arg506 → Gln mutation. Thrombosis Res. 81 (1996) 577-581
39. Rosendaal F.R. Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin. Hematol. 34 (1997) 171-187
40. Vandenbroucke J.P., Koster T., Briet E., Reitsma P.H., Bertina R.M., and Rosendaal F.R. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. (see comment). Lancet 344 (1994) 1453-1457
41. Welker G.C., Lookinland S., Tiedemanl M.E., and Beckstrand R.L. The role of genetics in the risk of thromboembolism: prothrombin 20210A and oral contraceptive therapy. J. Am. Acad. Nurse Pract 16 (2004) 106-115
42. Press R.D., Liu X.Y., Beamer N., and Coull B.M. Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C. Stroke 27 (1996) 44-48
43. Cushman M., Rosendaal F.R., Psaty B.M., Cook E.F., Valliere J., Kuller L.H., and Tracy R.P. Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study. Thromb. Haemostasis 79 (1998) 912-915
44. Acton R.T., Barton E.H., Hollowell W.W., Dreibelbis A.L., Go R.C., and Barton J.C. Ancestry reported by white adults with cutaneous melanoma and control subjects in central Alabama. BMC Cancer 4 (2004) 47
45. Barton E.H., Barton J.C., Hollowell W.W., and Acton R.T. Countries of ancestry reported by hemochromatosis probands and control subjects in central Alabama. Ethn. Dis. 14 (2004) 73-81
46. Kuffner T., Whitworth W., Jairam M., and McNicholl J. HLA class II and TNF genes in African Americans from the Southeastern United States: regional differences in allele frequencies. Hum. Immunol. 64 (2003) 639-647
47. Reed T.E. Caucasian genes in American Negroes. Science 165 (1969) 762-768
48. Reitnauer P.J., Go R.C., Acton R.T., Murphy C.C., Budowle B., Barger B.O., and Roseman J.M. Evidence for genetic admixture as a determinant in the occurrence of insulin-dependent diabetes mellitus in U.S. blacks. Diabetes 31 (1982) 532-537
49. Izaks G.J., Remarque E.J., Schreuder G.M., Westendorp R.G., and Ligthart G.J. The effect of geographic origin on the frequency of HLA antigens and their association with ageing. Eur. J. Immunogenet. 27 (2000) 87-92
50. H.A. U/S A Statistical Portrait of the American people (1983), Viking Press, New York